| Characteristics |
Number (%) |
| Gender |
|
| Male |
121 (54.0) |
| Female |
103 (46.0) |
| Age at presentation |
|
| Median age in days (IQR) |
150 (30-330) |
| ≤6 weeks |
65 (29.0) |
| >6 weeks – 6 months |
58 (25.9) |
| >6 months – 12 months |
63 (28.1) |
| >12 months |
38 (17.0) |
| GA |
|
| Mean (±SD) |
39.22 (1.92) |
| ≥37 weeks |
210 (93.8) |
| 37 weeks |
14 (6.2) |
| WAZ |
|
| Mean (±SD) |
-1.915 (2.14) |
| Underweight |
110 (49.1) |
| Not underweight |
114 (50.9) |
| HAZ |
|
| Median (IQR) |
-2.03 (-3.65 to 0.55) |
| Stunted |
113 (50.4) |
| Not stunted |
111 (49.6) |
| WHZ |
|
| Median (IQR) |
0.75 (-2.31 to 0.72) |
| Wasted |
68 (30.4) |
| Not wasted |
156 (69.6) |
| No. of children in the household |
|
| ≤4 |
86(38.4) |
| >4 |
138(61.6) |
| Delivery type |
|
| Elective C/S |
2 (0.9) |
| Emergent C/S |
6 (2.7) |
| Vaginal |
216 (96.4) |
| ROM |
|
| <4 hours |
129 (57.6) |
| ≥4 hours |
93 (41.5) |
| Nil |
2 (0.9) |
| ARV prophylaxis in Infants |
|
| NVP (6 weeks) |
42 (18.8) |
| sdNVP + ZDV (6 weeks) |
26 (11.6) |
| None |
156 (69.6) |
| HIV Screening outcome |
|
| Negative |
147 (65.6) |
| Positive |
77 (34.4) |
| Mode of HIV screening |
|
| DNA/PCR |
215 (95.9) |
| RVST |
9 (4.1) |
| Sources of referral |
|
| FMC |
71 (31.7 ) |
| Private 10 |
133 ( 59.4 ) |
| Government 10 +20 |
20 (8.9) |
C/S- Caesarean section, ROM= Rupture of membrane, RVST= HIV antibody test,
10=Primary health facility, 20= Secondary health facility |
